Synapse - William Pao

Results (141)

EGFR T790M decreases growth potential of lung tumor cells with drug-sensitive EGFR mutant alleles in the absence of drug selection

Meeting Abstract

Chmielecki, J.; Foo, J.; Somwar, R.; Regales, L.; Vivanco, I.; Shen, R.; Michor, F.; Pao, W.
Cancer Research (2009)

Fulltext@MSK | Save

Comparison of CISH and FISH for detection of EGFR copy number in lung adenocarcinomas and correlation with EGFR and KRAS mutation status and EGFR immunohistochemistry reactivity

Meeting Abstract

Varella, G. M.; Ladanyi, M.; Kris, M. G.; Rekhtman, N.; Hirsch, F.; Miller, V.; Riely, G.; Pao, W.; Zakowski, M. F.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Phase 1 trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib

Meeting Abstract

Riely, G. J.; Janjigian, Y. Y.; Pereira, L. K.; Azzoli, C. G.; Pietanza, M. C.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; more...
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Rebiopsy of patients with "acquired resistance" to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC)

Meeting Abstract

Miller, V. A.; Riely, G. J.; Arcila, M. E.; Oxnard, G.; Zakowski, M. F.; Kris, M. G.; Pao, W.; Ladanyi, M.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Phase II trial of dasatinib for patients demonstrating acquired resistance to treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) erlotinib (E) or gefitinib (G)

Meeting Abstract

Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Prognostic implications of EGFR and KRAS gene mutations in resected lung adenocarcinoma

Meeting Abstract

Janjigian, Y. Y.; Kris, M. G.; Pao, W.; Marks, J.; Zheng, J.; Shen, R.; Dycoco, J.; Park, B. J.; Riely, G. J.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Insulin-like growth factor-1 receptor expression in thymic malignancies

Meeting Abstract

Girard, N.; Teruya-Feldstein, J.; Riely, G. J.; Pao, W.; Rusch, V. W.; Kris, M.; Zakowski, M. F.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas thymomas

Meeting Abstract

Girard, N.; Shen, R.; Guo, T.; Zakowski, M. F.; Heguy, A.; Riely, G. J.; Huang, J.; Lau, C.; Lash, A.; Ladanyi, M.; more...
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

An internet-based protocol to collect clinical information and blood from patients with lung cancer who never smoked cigarettes: www.mskcc.org/neversmokerswithlungcancer

Meeting Abstract

Girard, N.; Klein, R.; Riely, G. J.; Reddy, R.; Kris, M. G.; Pao, W.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib

Journal Article

Zakowski, M. F.; Hussain, S.; Pao, W.; Ladanyi, M.; Ginsberg, M. S.; Heelan, R.; Miller, V. A.; Rusch, V. W.; Kris, M. G.
Archives of Pathology & Laboratory Medicine (2009)

Fulltext@MSK | Save